The vaccine is one of the three vaccines being used in India in the nationwide vaccination programme against Covid-19. The company has been facing questions over the delay in announcing results of phase-III trials.
The trial data is crucial as it will provide details of the efficacy of the vaccine, which was developed in association with the Indian Council of Medical Research. Phase-III trial data is also required for getting emergency use listing (EUL) from the World Health Organisation (WHO). WHO has accepted Bharat Biotech’s Expression of Interest (EoI) for EUL for Covaxin and scheduled a pre-submission meeting on June 23.
Over 85.15 lakh vaccine doses, the highest in a single day, were administered across the country on Monday as the revised guidelines for COVID-19 vaccination came into effect, the Union Health Ministry said. India’s cumulative COVID-19 vaccination coverage was recorded at over 28.36 crore since January 16, according to the data from the CoWIN portal.
“Today’s record-breaking vaccination numbers are gladdening. The vaccine remains our strongest weapon to fight COVID-19. Congratulations to those who got vaccinated and kudos to all the front-line warriors working hard to ensure so many citizens got the vaccine. Well done India!” Prime Minister Narendra Modi said. The previous single-day record was of over 48 lakh doses on April 1. In June so far, India saw an average vaccination of over 31 lakh per day.
The average single-day vaccinations fell to as low as around 16 lakh in the first week of May when the country was at the peak of the second wave. Madhya Pradesh saw the maximum vaccinations on Monday followed by Karnataka and Uttar Pradesh.